|
Market Closed -
Nasdaq
16:00:00 2026-10-08 EDT
|
5-day change | 1st Jan Change | ||
| 24.50 USD | +0.99% |
|
-1.09% | +60.03% |
| 09-25 | Xencor's XmAb819 Data Could Support Registrational Path, Wedbush Says | MT |
| 09-21 | BofA Adjusts Price Target on Xencor to $26 From $20, Keeps Neutral Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| XENCOR, INC. | Bio Therapeutic Drugs | +0.99% | -1.09% | +60.03% | +97.58% | -34.14% | 1.82B |  |  | |
- Stock Market
- Stocks
- XNCR Stock
- Charts Xencor, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
